STOK · Stoke Therapeutics, Inc.
Market Cap
$2.06B
Shares
64.53M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| Investor Event Transcript | 2026-08-12 | 2026-09-30 | |
| 8-K | 2026-08-03 | — | |
| 10-Q | 2026-08-03 | 2026-06-30 | |
| 8-K | 2026-08-03 | — | |
| 8-K | 2026-06-30 | — | |
| Investor Event Transcript | 2026-06-08 | 2026-06-30 | |
| 8-K | 2026-06-04 | 2026-06-03 | |
| Investor Event Transcript | 2026-06-04 | 2026-06-30 | |
| 10-Q | 2026-05-07 | 2026-03-31 | |
| 8-K | 2026-05-07 | — | |
| DEF 14A | 2026-04-22 | 2026-06-03 | |
| 8-K | 2026-04-07 | 2026-04-03 | |
| 8-K | 2026-03-27 | 2026-03-23 | |
| 10-K | 2026-03-16 | 2025-12-31 | |
| 8-K | 2026-03-03 | 2026-02-13 | |
| 8-K | 2026-01-26 | 2026-01-21 | |
| 8-K | 2026-01-12 | 2026-01-11 | |
| 8-K | 2025-12-05 | — | |
| 10-Q | 2025-11-04 | 2025-09-30 | |
| 8-K | 2025-11-04 | — | |
| 8-K | 2025-10-06 | 2025-10-05 | |
| 8-K/A | 2025-09-18 | 2025-06-03 | |
| 10-Q | 2025-08-12 | 2025-06-30 | |
| 8-K | 2025-08-12 | — | |
| 8-K | 2025-08-11 | — | |
| 8-K | 2025-07-10 | — | |
| 8-K | 2025-06-04 | 2025-06-03 | |
| 8-K | 2025-06-04 | — | |
| 10-Q | 2025-05-13 | 2025-03-31 | |
| 8-K | 2025-05-13 | — | |
| DEF 14A | 2025-04-22 | 2025-06-03 | |
| 8-K | 2025-03-18 | — | |
| 10-K | 2025-03-18 | 2024-12-31 | |
| 8-K | 2025-02-18 | 2025-02-14 | |
| 8-K | 2025-01-07 | — | |
| 8-K | 2024-12-06 | 2024-12-04 | |
| 8-K | 2024-11-05 | — | |
| 10-Q | 2024-11-05 | 2024-09-30 | |
| 8-K | 2024-09-10 | — | |
| 10-Q | 2024-08-07 | 2024-06-30 | |
| 8-K | 2024-08-07 | — | |
| 8-K | 2024-06-21 | 2024-06-18 | |
| 8-K | 2024-06-06 | 2024-06-05 | |
| 8-K | 2024-05-06 | — | |
| 10-Q | 2024-05-06 | 2024-03-31 | |
| 8-K | 2024-04-29 | — | |
| DEF 14A | 2024-04-23 | 2024-06-05 | |
| 8-K | 2024-03-28 | 2024-03-27 | |
| 8-K | 2024-03-25 | — | |
| 10-K | 2024-03-25 | 2023-12-31 |
Showing 1–50 of 120 filings
Key facts
CIK
1623526
CUSIP
86150R107
13F (30d)
181 filings
176 filers
Visit website
Investor relations